Comparing TerrAscend (TSNDF) and The Competition

TerrAscend (OTCMKTS:TSNDF) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare TerrAscend to related companies based on the strength of its institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings.

Risk and Volatility

TerrAscend has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, TerrAscend’s rivals have a beta of 2.53, meaning that their average share price is 153% more volatile than the S&P 500.

Institutional & Insider Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-31.01%	-32.93%	-5.49%
TerrAscend Competitors	-278.24%	-150.08%	-21.87%

Valuation & Earnings

This table compares TerrAscend and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TerrAscend	$260.56 million	-$81.33 million	-4.22
TerrAscend Competitors	$1.88 billion	$139.14 million	9.47

TerrAscend’s rivals have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and target prices for TerrAscend and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	0	2.00
TerrAscend Competitors	4274	10549	18323	829	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.34%. Given TerrAscend’s rivals stronger consensus rating and higher probable upside, analysts clearly believe TerrAscend has less favorable growth aspects than its rivals.

Summary

TerrAscend rivals beat TerrAscend on 9 of the 13 factors compared.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.